Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
New polyoxometallate–thiosemicarbazone hybrid compounds derived from pyridine‐2‐carbaldehyde thiosemicarbazone (HL), pyridine‐2‐carbaldehyde N4‐methylthiosemicarbazone (HL′) and their copper(II) complexes have been synthesized. Their formulae are (H2L)4(Mo8O26)(H2O)4 (1), [{(HL)2H}2(Mo6O19)]·C3H6O·0.24H2O (2), [(H2L′)4(HL′)2(Mo8O26)(H2O)2] (3), [{Cu(L)}4(Mo8O26)(H2O)4] (4), [{Cu(HL)(H2O)}2(Mo8O26)] (5), [{Cu(L′)}4(Mo8O26)(H2O)14] (6), Na6[{Cu(HL′)(H2O)2}4({Cu(L′)}2{Mo36O116(H2O)12})]·20H2O (7), [{Cu(HL)}2{Cu(L)}4{Mo36O112(H2O)16}(H2O)26] (8), [{Cu(HL′)}4{Mo36O112(H2O)16}(H2O)30] (9) and [{Cu(HL)(H2O)}2{Cu(L)S}2(H4V10O28)]n·6nH2O (10). Compounds 1–6 contain octamolybdate [Mo8O26]4– or hexamolybdate [Mo6O19]2– anions together with (H2L)+, (H2L′)+, [Cu(L)]+, [Cu(HL)(H2O)]2+ or [Cu(L′)]+ cations and neutral thiosemicarbazone molecules. The polyoxometallates (POMs) in 7–9 are [Mo36O116(H2O)12]16–, {Mo36} (7), and [Mo36O112(H2O)16]8–, {Mo36′} (8, 9). [Cu(HL′)]2+/[Cu(L′)]+ and [Cu(HL)]2+/[Cu(L)]+ units complete the respective lattices. Compound 10 consists of decavanadate anions (H4V10O28)2– and thiosemicarbazone‐copper(II) entities forming 1D [{Cu(HL)(H2O)}2{Cu(L)S}2(H4V10O28)]n structures connected through the hydrogen bonds of chains of water molecules. Structures of 2, 5, 7 and 10 have been characterized by single‐crystal X‐ray diffraction and other instrumental techniques (infrared, thermal analysis, electron paramagnetic resonance, nuclear magnetic resonance, magnetic susceptibility and mass spectrometry) were used to analyse all the compounds presented herein. The structural parameters of more than 1000 published thiosemicarbazone‐metal complexes have been used to determine some of the differences between metal complexes that contain anionic and neutral thiosemicarbazone ligands.
New polyoxometallate–thiosemicarbazone hybrid compounds derived from pyridine‐2‐carbaldehyde thiosemicarbazone (HL), pyridine‐2‐carbaldehyde N4‐methylthiosemicarbazone (HL′) and their copper(II) complexes have been synthesized. Their formulae are (H2L)4(Mo8O26)(H2O)4 (1), [{(HL)2H}2(Mo6O19)]·C3H6O·0.24H2O (2), [(H2L′)4(HL′)2(Mo8O26)(H2O)2] (3), [{Cu(L)}4(Mo8O26)(H2O)4] (4), [{Cu(HL)(H2O)}2(Mo8O26)] (5), [{Cu(L′)}4(Mo8O26)(H2O)14] (6), Na6[{Cu(HL′)(H2O)2}4({Cu(L′)}2{Mo36O116(H2O)12})]·20H2O (7), [{Cu(HL)}2{Cu(L)}4{Mo36O112(H2O)16}(H2O)26] (8), [{Cu(HL′)}4{Mo36O112(H2O)16}(H2O)30] (9) and [{Cu(HL)(H2O)}2{Cu(L)S}2(H4V10O28)]n·6nH2O (10). Compounds 1–6 contain octamolybdate [Mo8O26]4– or hexamolybdate [Mo6O19]2– anions together with (H2L)+, (H2L′)+, [Cu(L)]+, [Cu(HL)(H2O)]2+ or [Cu(L′)]+ cations and neutral thiosemicarbazone molecules. The polyoxometallates (POMs) in 7–9 are [Mo36O116(H2O)12]16–, {Mo36} (7), and [Mo36O112(H2O)16]8–, {Mo36′} (8, 9). [Cu(HL′)]2+/[Cu(L′)]+ and [Cu(HL)]2+/[Cu(L)]+ units complete the respective lattices. Compound 10 consists of decavanadate anions (H4V10O28)2– and thiosemicarbazone‐copper(II) entities forming 1D [{Cu(HL)(H2O)}2{Cu(L)S}2(H4V10O28)]n structures connected through the hydrogen bonds of chains of water molecules. Structures of 2, 5, 7 and 10 have been characterized by single‐crystal X‐ray diffraction and other instrumental techniques (infrared, thermal analysis, electron paramagnetic resonance, nuclear magnetic resonance, magnetic susceptibility and mass spectrometry) were used to analyse all the compounds presented herein. The structural parameters of more than 1000 published thiosemicarbazone‐metal complexes have been used to determine some of the differences between metal complexes that contain anionic and neutral thiosemicarbazone ligands.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.